The 3q Oncogene SEC62 Predicts Response to Neoadjuvant Chemotherapy and Regulates Tumor Cell Migration in Triple Negative Breast Cancer

In the absence of targeted treatment options, neoadjuvant chemotherapy (NACT) is applied widely for triple-negative breast cancer (TNBC). Response to NACT is an important parameter predictive of oncological outcomes (progression-free and overall survival). An approach to the evaluation of predictive...

Descripción completa

Detalles Bibliográficos
Autores principales: Radosa, Julia C., Kasoha, Mariz, Doerk, Merle, Cullmann, Annika, Kaya, Askin C., Linxweiler, Maximilian, Radosa, Marc P., Takacs, Zoltan, Tirincsi, Andrea, Lang, Sven, Jung, Martin, Puppe, Julian, Linxweiler, Barbara, Wagner, Mathias, Bohle, Rainer M., Solomayer, Erich-Franz, Zimmermann, Julia S. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253301/
https://www.ncbi.nlm.nih.gov/pubmed/37298528
http://dx.doi.org/10.3390/ijms24119576

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253301/
https://www.ncbi.nlm.nih.gov/pubmed/37298528
http://dx.doi.org/10.3390/ijms24119576

Ejemplares similares